SecBot SecBot
Insider Cluster (2 insiders) ·Filed Jul 2, 2026

XERS

Xeris Biopharma Holdings, Inc.
NEUTRAL
Impact 4/10
Horizondays Processed4mo ago
Insider cluster: 2 insiders, $856K total
Actionable Insight • Neutral

The insider sales are small and likely routine. Monitor for any upcoming earnings or pipeline catalysts that could explain the timing, but the cluster alone does not warrant a bearish stance.

DirectionNeutral
Confidencemedium
Horizondays

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$8.37
T+0 close · Jul 2, 2026 · via day close
Latest settled
+19.24%
T+60 · $9.98
Vs SPY
+17.52%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jul 6 $8.37entry
  2. T+1 · 4mo ago +6.81%α +7.29% · $8.94
  3. T+5 · 4mo ago −2.51%α −2.23% · $8.16
  4. T+20 · 4mo ago −2.87%α −3.72% · $8.13
  5. T+60 · 7w ago +19.24%α +17.52% · $9.98
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Two XERS insiders (Kevin McCulloch and Beth Hecht) sold a combined $856K in open-market sales on July 1, 2026, representing ~0.06% of the $1.4B market cap. Director Nerissa Kreher received a non-cash grant and a separate restricted stock award. The sales are small relative to market cap and may be routine portfolio diversification, but the cluster of two C-suite-level insiders selling on the same day warrants attention.

Key Financial Metrics

Direction
selling
Total Value
$856.4K
Insiders
2

Key Facts

  • Two insiders (Kevin McCulloch and Beth Hecht) sold a combined $856K in open-market sales on July 1, 2026.
  • Total sales represent ~0.06% of XERS's $1.4B market cap, well below the 0.1% materiality threshold.
  • Director Nerissa Kreher received a non-cash grant of 33,582 shares and a separate restricted stock award of 37,910 shares valued at $303,280.
  • The cluster is small in dollar terms and may reflect routine portfolio rebalancing or tax planning, not a bearish signal.

Financial Impact

Total insider sales of $856K represent ~0.06% of XERS's $1.4B market cap, immaterial from a proportionality perspective.

insider ownershipfloat

Risk Factors

  • Insider sales, while small, could indicate a lack of conviction ahead of a catalyst event.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
85% bullish (13 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-XERS-1783063139595

US Market Status

Market Closed · Opens in 5h 59m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 3, 2026